[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350942-105":59,"doc-detail-350942-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","the-expression-of-mercaptopyruvate-sulfurtransferase-serves-as-a-potential-biomarker-for-prognostic-stratification-and-immunotherapy-in-certain-cancers","The expression of mercaptopyruvate sulfurtransferase serves as a potential biomarker for prognostic stratiﬁcation and immunotherapy in certain cancers","","The study evaluates mercaptopyruvate sulfurtransferase (MPST) as a prognostic biomarker and potential link to immunotherapy response across cancers. Bioinformatic analyses integrate The Cancer Genome Atlas and Human Protein Atlas, assessing immune-related features and tumor microenvironment infiltration with TIMER2.0, protein interactions via STRING, methylation differences using UALCAN, and single-cell insights through cBioPortal and CancerSEA. Clinical tissue immunohistochemistry supports the bioinformatic findings, highlighting tumor–normal expression differences, immune-cell correlations, and methylation-associated effects linked to genetic alterations.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-expression-of-mercaptopyruvate-sulfurtransferase-serves-as-a-potential-biomarker-for-prognostic-stratification-and-immunotherapy-in-certain-cancers/350942/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-expression-of-mercaptopyruvate-sulfurtransferase-serves-as-a-potential-biomarker-for-prognostic-stratification-and-immunotherapy-in-certain-cancers/350942.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main purpose of the study on MPST?","Question",{"text":113,"@type":114},"To determine whether MPST expression can serve as a potential biomarker for prognostic stratification and immunotherapy relevance across certain cancers.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which data sources and analytical tools are used?",{"text":118,"@type":114},"The work uses The Cancer Genome Atlas and Human Protein Atlas, with TIMER2.0 for immune and microenvironment assessment, STRING for protein-protein interactions, UALCAN for methylation differences, and cBioPortal and CancerSEA for single-cell and functional-state insights, followed by immunohistochemical validation of clinical samples.",{"name":120,"@type":111,"acceptedAnswer":121},"What key findings connect MPST to cancer outcomes?",{"text":122,"@type":114},"MPST levels correlate with cancer outcomes, show significant expression differences between tumor and normal tissues in some cancer types, associate with immune cell presence and tumor immune microenvironment features, and relate to methylation patterns alongside genetic alterations.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},350942,1790438272,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":31,"preview_page_count":19,"preview_urls":145},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","TYPE Original Research PUBLISHED 14 January 2026 DOI 10.3389/fonc.2025.1686443  \nOPEN ACCESS  \nEDITED BY  \nRajesh Parsanathan,  \nCentral University of Tamil Nadu, India  \nREVIEWED BY  \nWeifeng Hong,  \nFudan University, China Yong Kuang,  \nCentral South University, China Fangshi Xu,  \nThe Second Afﬁliated Hospital of Xi’an Jiaotong University, China  \n*CORRESPONDENCE  \nJiexian Du  \n [28201963@hebmu.edu.cn](28201963@hebmu.edu.cn)[ ](28201963@hebmu.edu.cn)Zengfang Hao  \n [38145579@qq.com](38145579@qq.com)  \n†These authors have contributed equally to this work and share ﬁrst authorship  \nRECEIVED 15 August 2025  \nREVISED 12 December 2025  \nACCEPTED 23 December 2025  \nPUBLISHED 14 January 2026  \nCITATION  \nCui B, Xia C, Yang L, Xi X, Gong X, Liu Y, Tian C, Du X, Du J and Hao Z (2026) The expression of mercaptopyruvate sulfurtransferase serves as a potential biomarker for prognostic stratiﬁcation and immunotherapy in certain cancers.  \nFront. Oncol. 15:1686443 .  \ndoi: 10.3389/fonc.2025.1686443  \nCOPYRIGHT  \n© 2026 Cui, Xia, Yang, Xi, Gong, Liu, Tian, Du, Du and Hao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nThe expression of mercaptopyruvate sulfurtransferase serves asa potential biomarker for prognostic stratiﬁcation and immunotherapy in certain cancers  \nBoran Cui 1,2†, Chenchen Xia 2†, Li Yang 3†, Xiaoyu Xi 4, Xinxin Gong 5, Yixi Liu 6, Cai Tian 7, Xiaoli Du 8, Jiexian Du 1* and Zengfang Hao 9*  \n1 Department of Gynecology, The Second Hospital of Hebei Medical University, Shijiazhuang,  \nHebei, China, 2 Hebei Medical University, Shijiazhuang, Hebei, China, 3 Department of Gynecology, Xingtai Women and Children's Health, Xingtai, Hebei, China, 4 Department of Gynecology, Peking University People's Hospital, Beijing, China, 5 Hebei North University, Zhangjiakou, Hebei, China, 6Shandong First Medical University, Jinan, Shandong, China, 7 Department of Gynecological Ultrasound, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China, 8 Department of Gynecology, Shijiazhuang Hospital of Traditional Chinese Medicine, Shijiazhuang, Hebei, China, 9 Department of Pathology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China  \nIntroduction: 3 - Mercaptopyruvate Sulfurtransferase (3 - MST) is an enzyme encoded by the Mercaptopyruvate Sulfurtransferase (MPST) gene. The enzyme is associated with a variety of cancers such as lung adenocarcinoma. However, thereis a lack of comprehensive pan-cancer analysis on the potential impact of MPST on cancer diagnosis, prognosis, and immune response.  \nMethods: Based on data from The Cancer Genome Atlas and the Human Protein Atlas, we conducted a comprehensive bioinformatic analysis to investigate the oncogenic role of MPST . Immune-related characteristics and tumor microenvironment inﬁltration were assessed using TIMER2 .0. Protein-protein interaction networks were constructed via STRING, while DNA methylation differences across cancers were analyzed with UALCAN. Further insights into genetic alterations and functional states at the single-cell level were obtained from cBioPortal and CancerSEA. Finally, clinical samples were collected and subjected to immunohistochemical staining to preliminarily validate the bioinformatic ﬁndings. Result: The research assessed the links between MPST levels and various cancer outcomes, genetic alterations, immune cell presence, and DNA methylation patterns. Single-cell sequencing was utilized to deepen our comprehension of its functional importance. Furthermore, the unique immunohistochemical proﬁling of MPST inpatient tissu","cbCaikd2inxLsiJI","https://ap.wps.com/l/cbCaikd2inxLsiJI","pdf",29176839,"English","# Introduction\n## Methods\n## Results\n## Discussion","[{\"question\":\"What is the main purpose of the study on MPST?\",\"answer\":\"To determine whether MPST expression can serve as a potential biomarker for prognostic stratification and immunotherapy relevance across certain cancers.\"},{\"question\":\"Which data sources and analytical tools are used?\",\"answer\":\"The work uses The Cancer Genome Atlas and Human Protein Atlas, with TIMER2.0 for immune and microenvironment assessment, STRING for protein-protein interactions, UALCAN for methylation differences, and cBioPortal and CancerSEA for single-cell and functional-state insights, followed by immunohistochemical validation of clinical samples.\"},{\"question\":\"What key findings connect MPST to cancer outcomes?\",\"answer\":\"MPST levels correlate with cancer outcomes, show significant expression differences between tumor and normal tissues in some cancer types, associate with immune cell presence and tumor immune microenvironment features, and relate to methylation patterns alongside genetic alterations.\"}]","The expression of mercaptopyruvate sulfurtransferase serves as a potential biomarker for prognostic stratiﬁcation and immunotherapy in certain cancers | PDF",1790091932,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/efb81c4a500e7617cc375318c8cae4dd.webp",983,1389,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d37d0f6cdcc6b6f24d804c8250da6214.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aebd8c1a5481fc54f604210522b4ced4.webp",981,1386,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/10446027501f4ebf3c6c9d005580be16.webp",980,1385]